SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is trending as investors aggressively rotate into the fund to gain exposure to high-profile private companies, specifically SpaceX and Anthropic, ahead of expected IPO activity. The community is actively debating the fund's premium over its Net Asset Value compared to alternative vehicles, while closely watching for a potential short squeeze driven by the stock's relatively low float.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is facing intense investor scrutiny driven by legal challenges regarding NCAA trademarks and ongoing debates over the impact of emerging prediction market platforms. The community is sharply divided, with many actively loading up on short positions while others debate whether recent volatility represents a long-term accumulation opportunity.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing a significant surge in momentum as investors react to promising early clinical trial data from its new siRNA pipeline targeting rare muscle disorders, FSHD1 and DM1. While the community is actively debating the potential for a short squeeze and long-term valuation recovery, there is focused excitement regarding the company's best-in-class delivery platform and the strategic pivot toward these new programs.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is facing significant downward pressure as investors speculate on potential market share loss following the launch of a private-label energy drink by Costco, though many in the community dismiss this as a temporary overreaction. The stock is currently marked by intense debate between those aggressively buying the dip, citing strong brand loyalty and long-term growth, and critics who are increasingly vocal about perceived mismanagement and concerns over declining momentum.

Polywhale

KRILL is gaining significant social momentum as participants compare it to recent ocean-themed tokens and speculate on potential breakout patterns. Community members are actively discussing the coin's price action and broader market trends, fueling discussions about its potential for rapid growth.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA is currently facing significant volatility and market scrutiny following a critical short report from Culper Research, which has sparked intense debate between investors defending the company's fundamentals and those concerned by the allegations of channel stuffing. While management has dismissed the report as inaccurate and speculative, shareholders are actively monitoring institutional responses and awaiting a formal rebuttal to provide the clarity needed to stabilize investor sentiment.

The Shrimp Army

SHRIMPS is gaining traction within speculative crypto circles as traders draw parallels to previous successful meme coin runners. Community sentiment is highly bullish, with active discussion focusing on the token's potential to mirror the performance of other whale-themed assets in the sector.

ORCASM is a filthy little memecoin that knows exactly what you came for. It launched on Orca's Wavebreak but was born to make waves—wet, loud, and unforgettable. This isn’t your ordinary meme. ORCASM builds up the tension slow, goes deep, and leaves you gasping for more. It’s raw, unfiltered trencher energy dripping with shameless satisfaction. No promises. No roadmaps. Just pure, orcasmic pleasure.

Orcasm

Orcasm is trending as part of a surge in marine-themed meme coins, with community members actively discussing its potential for rapid price movement and speculative growth. Investors are debating the project's viability, with many comparing it to other ocean-themed tokens and highlighting it as a high-risk, high-reward opportunity.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as the community eagerly awaits long-term Week 40 trial data for Sonelokimab, which many view as a pivotal catalyst to validate its 'best-in-class' potential. Investors are actively debating the impact of upcoming conference presentations and ongoing M&A speculation, with high-conviction bulls emphasizing the strong institutional positioning and the potential for a paradigm shift in Hidradenitis Suppurativa treatment.

Navan, Inc. engages in offering a cloud-based technology platform for travelers. Its products include business travel and expense management. The company was founded by Ariel Cohen and Ilan Twig in February 2015 and is headquartered in Palo Alto, CA.

Navan Inc. - Ordinary Shares - Class A

Navan shares are seeing significant volatility as investors digest a strong earnings report featuring impressive revenue growth and margin expansion, alongside ongoing debates regarding the company's valuation and long-term path to profitability. While the community remains divided over the stock's recent performance, discussions are heavily focused on its AI-driven enterprise platform, insider buying activity, and the potential impact of its recent inclusion in major market indices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Atomic Alchemy is targeting criticality for the Groves facility by July 4, 2026.</li><li>The site is located near Lockhart in Caldwell County, Texas, and is part of the planned Proto-Town Innovation Hub.</li><li>The company reported FY25 net loss per share of $0.72, compared to $0.74 in FY24.</li></ul>Oklo Inc. (<a href="https://stocktwits.com/symbol/OKLO">OKLO</a>) on Tuesday said that the U.S. Department of Energy (DOE) has approved the Nuclear Safety Design Agreement (NSDA) for Atomic Alchemy’s Groves Isotopes Test Reactor in Texas under the DOE’s Reactor Pilot Program (RPP).&nbsp;The NSDA approval for Oklo’s wholly owned subsidiary follows the announcement of the signing of the Other Transaction Agreement (OTA) for the facility in January, and is a major milestone in DOE’s RPP authorization pathway, designed to speed execution and help expand U.S. industrial capacity through a framework that supports swift, scalable deployment, the firm said.&nbsp;“With DOE’s approval, we are making meaningful progress in the development of this isotope facility,” said Jacob DeWitte, co-founder and CEO of Oklo.<h2 class="st-heading-2">Facility Details</h2>With the NSDA approved, the facility moves into the next phase of project execution under DOE oversight by submitting its Preliminary Documented Safety Analysis (PDSA) for review. Atomic Alchemy is targeting criticality for the Groves facility by July 4, 2026.The site is located near Lockhart in Caldwell County, Texas, and is part of the planned Proto-Town Innovation Hub, a development intended to host demonstrations of new construction technologies and full-scale prototype buildings.The facility will help lay the groundwork for future commercial plants in the United States that produce isotopes to support cancer diagnosis and treatment, advanced manufacturing, scientific research, space exploration, and national security needs, the statement said.&nbsp;<h2 class="st-heading-2">FY25 Results</h2>The company reported FY25 net loss per share of $0.72, compared to $0.74 in FY24. Analysts, on average, expected FY25 loss per share of $0.62, according to data from Fiscal.ai.&nbsp;The company said that as of&nbsp;Dec. 31, 2025, it has&nbsp;cash and marketable securities of $1.4 billion, which comprised cash and equivalents of $788.4 million, and marketable securities of $624.1 million.<h2 class="st-heading-2">Retail reaction</h2>Retail sentiment around OKLO&nbsp;shares trended in&nbsp;the ‘extremely bullish’ territory amid ‘extremely high’ message volume.&nbsp;Shares in the company have fallen 18% year to date.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a person holds a smartphone displaying the logo of Oklo Inc.

OKLO Receives DOE’s Approval For Atomic Alchemy’s Groves Isotopes Test Reactor in Texas

The NSDA approval for Oklo’s wholly owned subsidiary follows the announcement of the signing of the Other Transaction Agreement (OTA) for the facility in January.

Equity

The NSDA approval for Oklo’s wholly owned subsidiary follows the announcement of the signing of the Other Transaction Agreement (OTA) for the facility in January.


Nuclear ETFs in Spotlight as Middle East Conflict Intensifies Energy Crisis

Middle East turmoil and surging oil prices are reigniting nuclear demand, putting ETFs like URA in focus as nations seek energy security.

<ul class="summary-bullets"><li>The company said that ORNL has been awarded funding under the U.S. Department of Energy’s GAIN initiative to collaborate with NuScale in this research program.</li><li>This award is a part of the first round of GAIN funding vouchers awarded in fiscal year 2026, NuScale added.</li><li>NuScale stated that the study with ORNL will evaluate ways to reduce fuel costs across multiple and single reactors.</li></ul>Shares of NuScale Power Corp. (SMR) gained more than 6% in Thursday’s opening trade after the company announced a new partnership to explore the use of AI in managing nuclear fuel.NuScale announced that it will team up with the Oak Ridge National Laboratory (ORNL) to utilize an AI-enabled nuclear design framework for a 12-NuScale Power Module (NPM) configuration.<h2 class="st-heading-2">What Is The Partnership About?</h2>NuScale stated that it will explore with ORNL how fuel could be managed even more efficiently and effectively across multiple reactors at a single site.The company said that ORNL has been awarded funding under the U.S. Department of Energy’s Gateway for Accelerated Innovation in Nuclear (GAIN) initiative to collaborate with NuScale in this research program. This award is a part of the first round of GAIN funding vouchers awarded in fiscal year 2026, NuScale added.“We are thrilled to be collaborating with ORNL, with the support of the DOE, to assess exciting new opportunities for potentially managing fuel even more efficiently across multiple nuclear reactors and further reducing costs going forward,” said NuScale President and CEO John Hopkins.<h2 class="st-heading-2">Study To Explore Ways To Reduce Costs</h2>NuScale stated that the study with ORNL will evaluate ways to reduce fuel costs across multiple and single reactors. The company said that, unlike large reactors, NuScale uses a multi-module architecture to enhance fuel efficiency.NuScale added that its architecture features up to 12 reactors with a single shared fuel pool and a wide range of fuel options. The company said that by sharing fuel across modules, it may find ways to improve overall plant fuel efficiency beyond what can normally be achieved in a single reactor plant, ultimately reducing costs.NuScale added that ORNL will bring its AI expertise, machine learning, fuel management, and computational resources to the table.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/SMR">NuScale Power</a> trended in the ‘neutral’ territory. SMR stock was among the top three trending tickers on the platform at the time of writing.A bullish user called NuScale a “real player in nuclear energy,” saying this is just the start.<stembedurl>https://stocktwits.com/Amit18/message/644779282</stembedurl>Another bullish user stated it would be worth watching when NuScale starts announcing contracts with big technology companies.<stembedurl>https://stocktwits.com/LieutenantJoe/message/644778184</stembedurl><a href="https://stocktwits.com/symbol/SMR">SMR stock</a> is up 16% year-to-date, but down 38% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/us-jobless-claims-report-february-7-2026-week/cZRTNa9R4ri">Jobless Claims Come In Slightly Higher Than Expectations, Continuing Claims Rise</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the NuScale Power Corporation (Nu Scale) logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

SMR Stock Rises As NuScale Announces Partnership To Explore AI-Guided Nuclear Fuel Management: Retail Calls It A ‘Real Player’

NuScale stated that it will explore with ORNL how fuel could be managed even more efficiently and effectively across multiple reactors at a single site.

ETFs Primed to Benefit From America's $2.7 Billion Nuclear Push

The DOE's $2.7 billion push to build U.S. uranium enrichment capacity could fuel a nuclear revival - and make ETFs like URA compelling plays. 

<ul class="summary-bullets"><li>ASP Isotopes’ collaboration with TerraPower focuses on constructing a new uranium enrichment facility in South Africa.&nbsp;</li><li>The agreement also ensures delivery of the initial fuel cores for TerraPower’s Natrium reactor in Wyoming.</li><li>Meta will fund the construction of up to eight Natrium plants, with delivery of initial units as early as 2032.</li></ul>ASP Isotopes Inc. (ASPI) stock drew a lot of investor attention on Friday after Meta Platforms (META) entered into a long-term agreement with TerraPower to secure a substantial supply of nuclear energy.In 2025, ASP Isotopes finalized several agreements with TerraPower to finance and supply fuel for advanced nuclear projects.<h2 class="st-heading-2">Advanced Enrichment Technology</h2>The company focuses on uranium enrichment, a process essential for powering modern nuclear reactors. Naturally occurring uranium is largely composed of U-238, which cannot sustain nuclear fission. To generate energy, reactors require U-235, which must be separated through a process known as enrichment.&nbsp;ASP Isotopes uses its proprietary Aerodynamic Separation Process, a method that increases efficiency and reduces costs compared with traditional techniques. The company’s strategy centers on producing High-Assay Low-Enriched Uranium (HALEU), the fuel necessary for small modular reactors (SMRs) and other advanced nuclear systems.<a href="https://stocktwits.com/symbol/ASPI">ASP Isotopes’ stock</a> traded over 13% higher in Friday’s premarket.<h2 class="st-heading-2">Agreement With TerraPower&nbsp;</h2>ASP Isotopes’ collaboration with TerraPower focuses on constructing a new uranium enrichment facility in South Africa and ensuring a long-term supply of HALEU for TerraPower’s Natrium reactor in Wyoming.The agreement ensures delivery of the initial fuel cores for TerraPower’s Natrium reactor in Wyoming, while a 10-year contract, starting in 2028, will supply up to 150 metric tons of HALEU through 2037.&nbsp;Friday’s agreement between Meta and TerraPower is significant because the tech giant will fund the construction of up to eight Natrium plants, with delivery of the initial units as early as 2032.<h2 class="st-heading-2">&nbsp;What Are Stocktwits Users Saying?</h2>On Stocktwits, retail sentiment around the stock improved to ‘extremely bullish’ from ‘bullish’ territory the previous day amid ‘high’ message volume levels.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_01_09_075629_png_abdb545c66.webp" alt="ASPI’s Sentiment Meter and Message Volume as of 07:30 a.m. ET on Jan. 9, 2026 | Source: Stocktwits" width="933" height="98"><figcaption>ASPI’s Sentiment Meter and Message Volume as of 07:30 a.m. ET on Jan. 9, 2026 | Source: Stocktwits</figcaption></figure>A bullish Stocktwits user suggested going long on the stock.<stembedurl>https://stocktwits.com/lefthanders/message/641313934</stembedurl>Another user expressed optimism about nuclear power.&nbsp;<stembedurl>https://stocktwits.com/mikesterz7/message/641312104</stembedurl>ASPI stock has gained over 43% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-vistra-stock-surge-pre-market-today/cmU2fYrR4de">Why Did Vistra Stock Surge 11% Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the ASP Isotopes logo is seen displayed on a smartphone screen. 

ASP Isotopes Stock Surged Over 13% Today – Why The Company Stands To Gain From Meta’s Nuclear Energy Deal With TerraPower

In 2025, ASP Isotopes finalized several agreements with TerraPower to finance and supply fuel for advanced nuclear projects.

<ul class="summary-bullets"><li>The firm stated that the derisked LWR design and the Tennessee Valley Authority’s licensing agreement bolster NuScale’s credibility.</li><li>The U.S. Nuclear Regulatory Commission approved NuScale’s uprated reactor design in May 2025.</li><li>NuScale’s uprated power module was the second small modular reactor design to have been approved by the NRC.</li></ul>Shares of NuScale Power Corp. (SMR) surged more than 12% in Friday’s pre-market trade. Analysts at BofA upgraded the stock following a correction of nearly 9% over the past month.According to TheFly, BofA upgraded NuScale Power to ‘Neutral’ from ‘Underperform’, but also trimmed the price target to $28 from $34. The firm’s new price target implies an upside of 42% from the SMR stock’s closing price on Thursday.<h2 class="st-heading-2">What Is BofA Saying?</h2>In its latest note, BofA stated that it now views NuScale’s deployments closer to its base case. The firm also noted that the derisked Light-Water Reactor (LWR) design and the Tennessee Valley Authority’s (TVA) licensing agreement bolster NuScale’s credibility.The U.S. Nuclear Regulatory Commission (NRC) approved NuScale’s uprated reactor design in May 2025, after the company revised the power module’s capacity upward to 77 megawatt-electric (MWe), from 50-MWe.NuScale’s uprated power module was the second small&nbsp;modular&nbsp;reactor (SMR) design to have been approved by the NRC.The TVA entered into an agreement with ENTRA1 Energy in September 2025 to deploy nuclear power capacity of up to six gigawatts using NuScale’s SMR technology.However, the firm added that the limited contract visibility caps the upside for the SMR stock in the near term.<h2 class="st-heading-2">Here’s What Stocktwits Users Think</h2>Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/SMR">NuScale Power</a> trended in the ‘extremely bullish’ territory. SMR stock was among the top three trending tickers on the platform at the time of writing.A bullish user stated that NuScale’s viability as a business could be proved amid anticipation of a “couple of major contracts.” The user also pointed to the government's efforts to streamline permits for nuclear power plants as a catalyst for the SMR stock.<stembedurl>https://stocktwits.com/Dlutsky/message/641308933</stembedurl>Another Stocktwits user stated that if AI adoption continues to accelerate this year, energy providers offering next-generation solutions could remain in the re-rating phase for a long time.<stembedurl>https://stocktwits.com/jonasono/message/641310411</stembedurl><a href="https://stocktwits.com/symbol/SMR">SMR stock</a> is up 39% year-to-date, but flat over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-big-oil-invest-at-least-100-billion-venezuela/cmU29w3R4d2">Trump Says Big Oil Will Invest At Least $100 Billion To Rebuild Venezuela's Oil Infrastructure</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

What Is Fueling SMR Stock's Surge Today?

BofA upgraded NuScale Power to ‘Neutral’ from ‘Underperform’, but also trimmed the price target to $28 from $34.

What's Driving the Surge in Rare Earth Stocks

Here's what you need to know about critical materials, the latest front in the trade war.

Nuclear ETFs Soar YTD Under Trump Regime, Top 2024 Performance 

Nuclear ETFs like NLR, URA and URAN surge in 2025 as Trump's policy push, rising uranium prices and SMR deployment fuel solid gains. 

ETFs to Play the Potential $10 Trillion Nuclear Surge

Nuclear power is surging as AI-driven data centers fuel demand, with ETFs riding momentum and SMRs reshaping the sector's future.

The U.S. and UK are set to sign a deal that will bolster the deployment of new nuclear power stations, the British government said.The agreement is expected to be signed by British Prime Minister Keir Starmer and U.S. President Donald Trump during the latter’s two-day visit to the UK beginning Tuesday. Among other things, the deal will simplify the process for obtaining a license for a nuclear project, expediting the timeline from about three to four years to two years.“Together with the U.S., we’re building a golden age of nuclear that puts both countries at the forefront of global innovation and investment,” Starmer said in a statement.Among major tie-ups, U.S.-based X-Energy and Britain’s Centrica are planning to build up to 12 advanced modular reactors in Hartlepool, in the northeast of England. The companies projected that the Hartlepool project will generate enough power for up to 1.5 million homes and deliver an economic value of at least 40 billion pounds ($54.2 billion).“Together, we aim to build a fleet that will reliably deliver clean power, strengthen energy security, and grow the trans-Atlantic economy for decades to come,” J. Clay Sell, CEO of X-Energy said.Separately, U.S. firm Holtec International, France's EDF and real estate firm Tritax, plan to develop advanced data centres powered by small modular reactors at the former Cottam coal-fired power station in Nottinghamshire. Holtec estimated that the project is valued at 11 billion pounds and will create thousands of construction jobs.The U.S. and UK are also exploring a ramp-up of the production of high-assay low-enriched uranium (HALEU) to reduce their reliance on Russia. &nbsp;Bill Gates-backed TerraPower and U.S.-based engineering firm KBR also plan to conduct studies and evaluate sites in the UK for the deployment of the Natrium advanced reactor technology.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/KBR">KBR </a>was in the ‘neutral’ territory at the time of writing, while traders were bullish about the <a href="https://stocktwits.com/symbol/NLR">VanEck Uranium Nuclear Energy ETF</a>.The renewed push in nuclear comes amid a surge in global electricity demand, driven by AI data centers. In November last year, the UK and 30 other countries agreed to triple their nuclear capacity by 2050.Power equipment maker GE Vernova also welcomed the development and noted that regulatory simplification and harmonisation will help to reduce costs and speed up the construction of the “first wave of SMR plants.”Also See: <a href="https://stocktwits.com/news-articles/markets/equity/space-x-sends-northrop-grumman-s-large-cargo-ship-to-orbit-in-its-debut-flight/chwvvdqRdxE">SpaceX Sends Northrop Grumman’s Large Cargo Ship To Orbit In Its Debut Flight</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Cooling towers of a nuclear power plant in Oxford, UK.

Trump, Starmer to Sign US-UK Nuclear Deal To Expedite Small Reactor Deployments

The deal will expedite the timeline for obtaining a license for a nuclear project from about three to four years to two years.

NLR
VanEck Uranium Nuclear Energy ETF

Feed

News

Sentiment

Fundamentals

Info

Latest NLR News

NLRVanEck Uranium Nuclear Energy ETF